Lead in Hair Dyes Must Go: FDA
TUESDAY, Oct. 30, 2018 — The U.S. Food and Drug Administration on Tuesday said that hair dyes can no longer […]
» Read moreMONDAY, Oct. 1, 2018 — Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat […] MONDAY, Sept. 10, 2018 — Cassipa (buprenorphine and naloxone), a film designed to be placed under the tongue, has been […] TUESDAY, Sept. 4, 2018 — Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because […] One veteran that attempted suicide five times finds that MDMA treatment is effective in treating his mental illnesses. An Iraq […] (HealthDay)—The U.S. Food and Drug Administration is warning patients with cancers of the blood or lymph nodes who undergo a […] Many women who have gone through a vaginal birth, or through menopause, may experience laxity of the vaginal canal, damage […] Krintafel flushes the malaria-causing parasite from the liver, preventing relapse and the spread of recurring malaria. The U.S. Food and […] (HealthDay)—A powerful class of antibiotics will now come with stronger safety warnings about dangerous drops in blood sugar and neurological […] July 10, 2018 — The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of […]
FDA Approves New Treatment for Squamous Cell Carcinoma
FDA Approves New Treatment for Opioid Dependence
FDA: Montelukast Tablet Bottles Recalled
Veteran Treated PTSD And Suicidal Thoughts With ‘Life-Altering’ MDMA Therapy
FDA warns against long-term azithromycin use for some
‘Vaginal rejuvenation’ devices ‘have serious risks,’ warn FDA
First Malaria Drug In 60 Years Approved By FDA Described As A ‘Phenomenal Achievement’
FDA slaps stronger warnings on potent class of antibiotics
FDA Updates Warnings for Fluoroquinolone Antibiotics on Risks of Mental Health and Low Blood Sugar Adverse Reactions
